Where is Copea located?

Copea is headquartered in Liverpool, United Kingdom.

Is Copea a funded company?

Copea is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Copea rank among its competitors?

Copea ranks 994th amongst 1343 active competitors, of which 25 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Prescient Healthcare Group, which secured $18.3K in Jun, 2024.

Who are the top competitors of Copea?

Copea's top competitors include Indegene, IntegriChain and Zuellig Pharma. Among them, Prescient Healthcare Group secured the most recent funding round in June, 2024.

Copea - 2026 Company Profile & Competitors

Copea is an unfunded company based in Liverpool (United Kingdom), founded in 2013. It operates as a Provider of auditing, project management, and QA services. Copea has not raised any funding yet. The company has 1343 active competitors, including 25 funded and 146 that have exited. Its top competitors include companies like Indegene, IntegriChain and Zuellig Pharma.

Company Details

Website: copeapharma.com
Social

Key Metrics

Founded Year

2013

Location

Liverpool, United Kingdom

Stage

Unfunded

Ranked

994^th among 1343 active competitors

Similar Companies

Indegene & 1602 more

View Copea's full profile

Copea has not raised any funding rounds yet.

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Copea include Indegene, IntegriChain and Zuellig Pharma. Here is the list of Top 10 competitors of Copea, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Indegene 1998, Princeton (United States), Public	Suite solutions for payers and healthcare providers	$255M	Syneos Health, Cadawninvestmentcompany & 17 others	76/100
2nd	IntegriChain 2005, Philadelphia (United States), Acquired	Pharma commercialization solutions: data, consulting, and technology for market access	$2M	Activate Venture Partners, SaaS Capital & 4 others	65/100
3rd	Zuellig Pharma 1992, Singapore (Singapore), Funding Raised	Provider of clinical research, quality management, logistics, and clinical trial supply services	-	Temasek	64/100
4th	EVERSANA 2014, Milwaukee (United States), Funding Raised	Provider of consulting services for drug pricing access, reimbursement, and regulatory support	-	ACE & Company, North Sky Capital & 2 others	61/100
5th	Prescient Healthcare Group 2007, London (United Kingdom), Series B	Consulting services for product strategy and decision support	$12.7M	Intertrust, Bridgepoint Group & 7 others	59/100
6th	Fishawack 2001, Brighton (United Kingdom), Acquired	Provider of fully-integrated, cross-border services to global pharmaceutical organisations	$23.6M	-	58/100
7th	CMIC HOLDINGS 1985, Tokyo (Japan), Acquired	Contract service provider for biopharma companies	-	-	58/100
8th	Diaceutics 2005, Belfast (United Kingdom), Public	Analytics based integrator for precision medicine	-	Herald Investment Management, SVB & 4 others	57/100
9th	Fabtech 2002, Mumbai (India), Public	Provider of instruments for biotech, pharmaceutical, and biomedical industries	$175K	Acaciaa International TR LLC, T Square Enterprises ... & 9 others	60/100
10th	Clinigen 2010, Burton-on-trent (United Kingdom), Acquired	Services in clinical trials & medicine supply	-	RBS Group, Santander Bank & 3 others	56/100
994th	Copea 2013, Liverpool (United Kingdom), Unfunded	Provider of auditing, project management, and QA services	-	-	16/100